VAUGHAN, ON, Nov. 7, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) today is providing a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"), which require the Company to provide bi-weekly updat

TOLEDO, Ohio, Nov. 7, 2019 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a collaboration with Welltower Inc. (NYSE: WELL) and Sunrise Senior Living, to bring its state-of-the-art elder technology safety platform, which combines wearable devices with cloud-based capabilities, to Welltower's flagship senior

COLUMBIA, Md., Nov. 7, 2019 /PRNewswire/ -- The Maryland Stem Cell Research Commission (Commission) issued a Request for Applications (RFAs) for its second round of funding for fiscal year 2020 and is looking to continue funding cutting-edge research and accelerating cures through the

AUSTIN, Texas, Nov. 7, 2019 /PRNewswire/ -- When the Hunt Cancer Institute at Torrance Memorial Medical Center opens next month, Southern California cancer patients will have access to state-of-the-art care and technology innovations, including Allen Technologies' E3 Patient Engagement Solutions.

COLD SPRING HARBOR, N.Y., Nov. 7, 2019 /PRNewswire/ -- Cold Spring Harbor Laboratory (CSHL) hosted the 14th annual Double Helix Medals dinner (DHMD) on November 6th and raised $4.5 million to support basic research. Held at the American Museum of Natural History in New York City

ALBUQUERQUE, N.M., Nov. 7, 2019 /PRNewswire/ -- Armonica Technologies, Inc., a biotechnology company developing high throughput and cost-effective long-read DNA sequencing technology, announced that its Board of Directors has appointed Victor Esch, PhD, to the position of President and Chief Executive Officer.

WATERTOWN, Mass. and RESEARCH TRIANGLE PARK, N.C., Nov. 7, 2019 /PRNewswire/ -- SQZ Biotechnologies (SQZ), and Asklepios BioPharmaceutical, Inc. (AskBio), announced a research collaboration to create tolerizing antigen carriers (TACs) containing AAV (adeno-associated virus) components to solve one of gene therapy's biggest challenges

CEDAR KNOLLS, N.J., Nov. 7, 2019 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, an innovative proprietary bioactive composition made from fertilized egg yolks that helps build lean muscle, today announced its financial results for the three and

TEL AVIV, Israel, Nov. 7, 2019 /PRNewswire/ -- Therapix Biosciences Ltd. ("Therapix" or the "Company") (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, along with Destiny Biosciences Global Corp. ("Destiny"), announced today the mutual decision to discontinue negotiations on the previously ann

THOUSAND OAKS, Calif., Nov. 7, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 28th Annual Credit Suisse Healthcare Conference at 9:45 a.m. MT on Tuesday, Nov. 12, 2019, in Scottsdale, Ariz. David W. Meline, executive vice president and chief financial officer at Amgen, will prese